Holman Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Holman Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
Medical Therapies of Cushing's Disease-Part 1
Endocrinology & metabolism clinics of North America. 2025 Dec ; 54:609-626
Medical Therapies of Cushing's Disease-Part 2
Endocrinology & metabolism clinics of North America. 2025 Dec ; 54:627-635
Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study
Pituitary. 2025 Oct 22; 28:116
RAGE-mediated activation of the formin DIAPH1 and human macrophage inflammation are inhibited by a small molecule antagonist
Cell chemical biology. 2025 Oct 16; 32:1221-1234.e8
Extracellular Vesicles From Chylomicron-Treated Endothelial Cells Drive Macrophage Inflammation
Arteriosclerosis, thrombosis, & vascular biology. 2025 Oct 16;
DNA methylation profiling of pituitary neuroendocrine tumors identifies distinct clinical and pathological subtypes based on epigenetic differentiation
Neuro-oncology. 2025 Oct 14; 27:2341-2354
Development and validation of clinical screening systems for Cushing disease in the United States
Pituitary. 2025 Oct 10; 28:108
Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease
Alzheimer's & dementia. 2025 Oct ; 21:e70765